{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:39:03Z","timestamp":1792535943832,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"43","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303472"],"award-info":[{"award-number":["82303472"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M721518"],"award-info":[{"award-number":["2022M721518"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,11,11]]},"DOI":"10.1038\/s41388-026-03976-6","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:47:32Z","timestamp":1789141652000},"page":"4613-4629","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor-derived CTHRC1 mediates ITGB3-dependent osteoclast differentiation to promote prostate cancer bone metastasis"],"prefix":"10.1038","volume":"45","author":[{"given":"Tao","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianming","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoping","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Zhong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiehui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2544-302X","authenticated-orcid":false,"given":"Ming-Kun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8289-097X","authenticated-orcid":false,"given":"Zhe-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Lu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1162-8077","authenticated-orcid":false,"given":"Shan-Chao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"3976_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"key":"3976_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4:47\u201353. https:\/\/doi.org\/10.1016\/j.jncc.2024.01.006.","journal-title":"J Natl Cancer Cent"},{"key":"3976_CR3","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.euo.2023.09.015","volume":"7","author":"N Romero-Laorden","year":"2024","unstructured":"Romero-Laorden N, Lorente D, de Velasco G, Lozano R, Herrera B, Puente J, et al. Prospective assessment of bone metabolism biomarkers and survival in metastatic castration-resistant prostate cancer patients treated with Radium-223: The PRORADIUM Study. Eur Urol Oncol. 2024;7:447\u201355. https:\/\/doi.org\/10.1016\/j.euo.2023.09.015.","journal-title":"Eur Urol Oncol"},{"key":"3976_CR4","doi-asserted-by":"publisher","first-page":"e242467","DOI":"10.1001\/jamanetworkopen.2024.2467","volume":"7","author":"W Fukuokaya","year":"2024","unstructured":"Fukuokaya W, Mori K, Urabe F, Igarashi T, Yanagisawa T, Tsuzuki S, et al. Bone-modifying agents in patients with high-risk metastatic castration-sensitive prostate cancer treated with abiraterone acetate. JAMA Netw Open. 2024;7:e242467. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.2467.","journal-title":"JAMA Netw Open"},{"key":"3976_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013020.pub2","volume":"12","author":"T Jakob","year":"2020","unstructured":"Jakob T, Tesfamariam YM, Macherey S, Kuhr K, Adams A, Monsef I, et al. Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis. Cochrane Database Syst Rev. 2020;12:CD013020. https:\/\/doi.org\/10.1002\/14651858.CD013020.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"3976_CR6","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s13046-022-02520-0","volume":"41","author":"R Dai","year":"2022","unstructured":"Dai R, Liu M, Xiang X, Xi Z, Xu H. Osteoblasts and osteoclasts: an important switch of tumour cell dormancy during bone metastasis. J Exp Clin Cancer Res. 2022;41:316. https:\/\/doi.org\/10.1186\/s13046-022-02520-0.","journal-title":"J Exp Clin Cancer Res"},{"key":"3976_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","volume":"6","author":"RE Coleman","year":"2020","unstructured":"Coleman RE, Croucher PI, Padhani AR, Clezardin P, Chow E, Fallon M, et al. Bone metastases. Nat Rev Dis Prim. 2020;6:83. https:\/\/doi.org\/10.1038\/s41572-020-00216-3.","journal-title":"Nat Rev Dis Prim"},{"key":"3976_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423:337\u201342. https:\/\/doi.org\/10.1038\/nature01658.","journal-title":"Nature"},{"key":"3976_CR9","doi-asserted-by":"publisher","unstructured":"Kim JM, Lin C, Stavre Z, Greenblatt MB, Shim JH. Osteoblast-Osteoclast Communication and Bone Homeostasis. Cells. 2020;9. https:\/\/doi.org\/10.3390\/cells9092073.","DOI":"10.3390\/cells9092073"},{"key":"3976_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrc3055","volume":"11","author":"KN Weilbaecher","year":"2011","unstructured":"Weilbaecher KN, Guise TA, McCauley LK. Cancer to bone: a fatal attraction. Nat Rev Cancer. 2011;11:411\u201325. https:\/\/doi.org\/10.1038\/nrc3055.","journal-title":"Nat Rev Cancer"},{"key":"3976_CR11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1152\/physrev.00043.2020","volume":"102","author":"J Delgado-Calle","year":"2022","unstructured":"Delgado-Calle J, Bellido T. The osteocyte as a signaling cell. Physiol Rev. 2022;102:379\u2013410. https:\/\/doi.org\/10.1152\/physrev.00043.2020.","journal-title":"Physiol Rev"},{"key":"3976_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.trecan.2020.09.006","volume":"7","author":"G Furesi","year":"2021","unstructured":"Furesi G, Rauner M, Hofbauer LC. Emerging players in prostate cancer-bone niche communication. Trends Cancer. 2021;7:112\u201321. https:\/\/doi.org\/10.1016\/j.trecan.2020.09.006.","journal-title":"Trends Cancer"},{"key":"3976_CR13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1152\/physrev.00012.2019","volume":"101","author":"P Clezardin","year":"2021","unstructured":"Clezardin P, Coleman R, Puppo M, Ottewell P, Bonnelye E, Paycha F, et al. Bone metastasis: mechanisms, therapies, and biomarkers. Physiol Rev. 2021;101:797\u2013855. https:\/\/doi.org\/10.1152\/physrev.00012.2019.","journal-title":"Physiol Rev"},{"key":"3976_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/14728222.2024.2349686","volume":"28","author":"CK Singh","year":"2024","unstructured":"Singh CK, Fernandez S, Chhabra G, Zaemisch GR, Nihal A, Swanlund J, et al. The role of collagen triple helix repeat containing 1 (CTHRC1) in cancer development and progression. Expert Opin Ther Targets. 2024;28:419\u201335. https:\/\/doi.org\/10.1080\/14728222.2024.2349686.","journal-title":"Expert Opin Ther Targets"},{"key":"3976_CR15","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.7150\/ijbs.79260","volume":"19","author":"D Wang","year":"2023","unstructured":"Wang D, Zhang Y, Ye T, Zhang R, Zhang L, Shi D, et al. Cthrc1 deficiency aggravates wound healing and promotes cardiac rupture after myocardial infarction via non-canonical WNT5A signaling pathway. Int J Biol Sci. 2023;19:1299\u2013315. https:\/\/doi.org\/10.7150\/ijbs.79260.","journal-title":"Int J Biol Sci"},{"key":"3976_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41413-018-0019-6","volume":"6","author":"Y Han","year":"2018","unstructured":"Han Y, You X, Xing W, Zhang Z, Zou W. Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts. Bone Res. 2018;6:16. https:\/\/doi.org\/10.1038\/s41413-018-0019-6.","journal-title":"Bone Res"},{"key":"3976_CR17","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s43657-025-00221-0","volume":"5","author":"M Chu","year":"2025","unstructured":"Chu M, Zhang Y, Chen J, Cong H, Yin Y, Chen H. Breast cancer bone metastasis: novel prognostic biomarkers identified. Phenomics. 2025;5:404\u201317. https:\/\/doi.org\/10.1007\/s43657-025-00221-0.","journal-title":"Phenomics"},{"key":"3976_CR18","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47. https:\/\/doi.org\/10.1093\/nar\/gkv007.","journal-title":"Nucleic Acids Res"},{"key":"3976_CR19","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.1073\/pnas.1902651116","volume":"116","author":"W Abida","year":"2019","unstructured":"Abida W, Cyrta J, Heller G, Prandi D, Armenia J, Coleman I, et al. Genomic correlates of clinical outcome in advanced prostate cancer. Proc Natl Acad Sci USA. 2019;116:11428\u201336. https:\/\/doi.org\/10.1073\/pnas.1902651116.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3976_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01630-9","volume":"21","author":"T Xie","year":"2022","unstructured":"Xie T, Fu DJ, Li ZM, Lv DJ, Song XL, Yu YZ, et al. CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322\/CCL20\/CCR6 signaling. Mol Cancer. 2022;21:173. https:\/\/doi.org\/10.1186\/s12943-022-01630-9.","journal-title":"Mol Cancer"},{"key":"3976_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30105-0","volume":"13","author":"L Zhang","year":"2022","unstructured":"Zhang L, Qu J, Qi Y, Duan Y, Huang YW, Zhou Z, et al. EZH2 engages TGFbeta signaling to promote breast cancer bone metastasis via integrin beta1-FAK activation. Nat Commun. 2022;13:2543. https:\/\/doi.org\/10.1038\/s41467-022-30105-0.","journal-title":"Nat Commun"},{"key":"3976_CR22","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671\u20135. https:\/\/doi.org\/10.1038\/nmeth.2089.","journal-title":"Nat Methods"},{"key":"3976_CR23","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41571-021-00499-9","volume":"18","author":"LC Hofbauer","year":"2021","unstructured":"Hofbauer LC, Bozec A, Rauner M, Jakob F, Perner S, Pantel K. Novel approaches to target the microenvironment of bone metastasis. Nat Rev Clin Oncol. 2021;18:488\u2013505. https:\/\/doi.org\/10.1038\/s41571-021-00499-9.","journal-title":"Nat Rev Clin Oncol"},{"key":"3976_CR24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1152\/physiol.00061.2014","volume":"31","author":"JA Siddiqui","year":"2016","unstructured":"Siddiqui JA, Partridge NC. Physiological bone remodeling: systemic regulation and growth factor involvement. Physiology. 2016;31:233\u201345. https:\/\/doi.org\/10.1152\/physiol.00061.2014.","journal-title":"Physiology"},{"key":"3976_CR25","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrc2694","volume":"9","author":"EF Wagner","year":"2009","unstructured":"Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer. 2009;9:537\u201349. https:\/\/doi.org\/10.1038\/nrc2694.","journal-title":"Nat Rev Cancer"},{"key":"3976_CR26","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.7150\/ijbs.76162","volume":"18","author":"F Li","year":"2022","unstructured":"Li F, Xu T, Chen P, Sun R, Li C, Zhao X, et al. Platelet-derived extracellular vesicles inhibit ferroptosis and promote distant metastasis of nasopharyngeal carcinoma by upregulating ITGB3. Int J Biol Sci. 2022;18:5858\u201372. https:\/\/doi.org\/10.7150\/ijbs.76162.","journal-title":"Int J Biol Sci"},{"key":"3976_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18081-9","volume":"11","author":"P Fuentes","year":"2020","unstructured":"Fuentes P, Sese M, Guijarro PJ, Emperador M, Sanchez-Redondo S, Peinado H, et al. ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells. Nat Commun. 2020;11:4261. https:\/\/doi.org\/10.1038\/s41467-020-18081-9.","journal-title":"Nat Commun"},{"key":"3976_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00577-x","volume":"12","author":"Y Duan","year":"2024","unstructured":"Duan Y, Kong P, Huang M, Yan Y, Dou Y, Huang B, et al. STAT3-mediated up-regulation of DAB2 via SRC-YAP1 signaling axis promotes Helicobacter pylori-driven gastric tumorigenesis. Biomark Res. 2024;12:33. https:\/\/doi.org\/10.1186\/s40364-024-00577-x.","journal-title":"Biomark Res"},{"key":"3976_CR29","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1172\/JCI93707","volume":"128","author":"Q Sun","year":"2018","unstructured":"Sun Q, Lesperance J, Wettersten H, Luterstein E, DeRose YS, Welm A, et al. Proapoptotic PUMA targets stem-like breast cancer cells to suppress metastasis. J Clin Invest. 2018;128:531\u201344. https:\/\/doi.org\/10.1172\/JCI93707.","journal-title":"J Clin Invest"},{"key":"3976_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12929-022-00824-z","volume":"29","author":"TH Jang","year":"2022","unstructured":"Jang TH, Huang WC, Tung SL, Lin SC, Chen PM, Cho CY, et al. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin\/FAK\/Src\/ERK\/beta-catenin pathway. J Biomed Sci. 2022;29:42. https:\/\/doi.org\/10.1186\/s12929-022-00824-z.","journal-title":"J Biomed Sci"},{"key":"3976_CR31","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1161\/CIRCULATIONAHA.119.044557","volume":"142","author":"A Ruiz-Villalba","year":"2020","unstructured":"Ruiz-Villalba A, Romero JP, Hernandez SC, Vilas-Zornoza A, Fortelny N, Castro-Labrador L, et al. Single-cell RNA sequencing analysis reveals a crucial role for CTHRC1 (Collagen Triple Helix Repeat Containing 1) Cardiac Fibroblasts After Myocardial Infarction. Circulation. 2020;142:1831\u201347. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.044557.","journal-title":"Circulation"},{"key":"3976_CR32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1161\/01.RES.0000154262.07264.12","volume":"96","author":"P Pyagay","year":"2005","unstructured":"Pyagay P, Heroult M, Wang Q, Lehnert W, Belden J, Liaw L, et al. Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration. Circ Res. 2005;96:261\u20138. https:\/\/doi.org\/10.1161\/01.RES.0000154262.07264.12.","journal-title":"Circ Res"},{"key":"3976_CR33","doi-asserted-by":"publisher","unstructured":"Sawada Y, Kikugawa T, Onishi T, Arai O, Iio H, Miura N, et al. CTHRC1 promotes bone metastasis in prostate cancer. Int J Cancer. 2025. https:\/\/doi.org\/10.1002\/ijc.70012.","DOI":"10.1002\/ijc.70012"},{"key":"3976_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33780-1","volume":"13","author":"HY Wong","year":"2022","unstructured":"Wong HY, Sheng Q, Hesterberg AB, Croessmann S, Rios BL, Giri K, et al. Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease. Nat Commun. 2022;13:6036. https:\/\/doi.org\/10.1038\/s41467-022-33780-1.","journal-title":"Nat Commun"},{"key":"3976_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e35727","volume":"10","author":"Y Bian","year":"2024","unstructured":"Bian Y, Chang X, Hu X, Li B, Song Y, Hu Z, et al. Exosomal CTHRC1 from cancer-associated fibroblasts facilitates endometrial cancer progression via ITGB3\/FAK signaling pathway. Heliyon. 2024;10:e35727. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35727.","journal-title":"Heliyon"},{"key":"3976_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02266-3","volume":"21","author":"D Peng","year":"2021","unstructured":"Peng D, Wei C, Zhang X, Li S, Liang H, Zheng X, et al. Pan-cancer analysis combined with experiments predicts CTHRC1 as a therapeutic target for human cancers. Cancer Cell Int. 2021;21:566. https:\/\/doi.org\/10.1186\/s12935-021-02266-3.","journal-title":"Cancer Cell Int"},{"key":"3976_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9578701","volume":"2020","author":"D Mei","year":"2020","unstructured":"Mei D, Zhu Y, Zhang L, Wei W. The Role of CTHRC1 in regulation of multiple signaling and tumor progression and metastasis. Mediat Inflamm. 2020;2020:9578701. https:\/\/doi.org\/10.1155\/2020\/9578701.","journal-title":"Mediat Inflamm"},{"key":"3976_CR38","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1161\/01.RES.0000260806.99307.72","volume":"100","author":"RJ LeClair","year":"2007","unstructured":"LeClair RJ, Durmus T, Wang Q, Pyagay P, Terzic A, Lindner V. Cthrc1 is a novel inhibitor of transforming growth factor-beta signaling and neointimal lesion formation. Circ Res. 2007;100:826\u201333. https:\/\/doi.org\/10.1161\/01.RES.0000260806.99307.72.","journal-title":"Circ Res"},{"key":"3976_CR39","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ccell.2020.05.022","volume":"38","author":"H Yuan","year":"2020","unstructured":"Yuan H, Han Y, Wang X, Li N, Liu Q, Yin Y, et al. SETD2 restricts prostate cancer metastasis by integrating EZH2 and AMPK signaling pathways. Cancer Cell. 2020;38:350\u201365 e7. https:\/\/doi.org\/10.1016\/j.ccell.2020.05.022.","journal-title":"Cancer Cell"},{"key":"3976_CR40","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41392-024-01937-7","volume":"9","author":"Y Wang","year":"2024","unstructured":"Wang Y, Jia J, Wang F, Fang Y, Yang Y, Zhou Q, et al. Pre-metastatic niche: formation, characteristics and therapeutic implication. Signal Transduct Target Ther. 2024;9:236. https:\/\/doi.org\/10.1038\/s41392-024-01937-7.","journal-title":"Signal Transduct Target Ther"},{"key":"3976_CR41","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.canlet.2022.01.015","volume":"530","author":"J Kang","year":"2022","unstructured":"Kang J, La Manna F, Bonollo F, Sampson N, Alberts IL, Mingels C, et al. Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer. Cancer Lett. 2022;530:156\u201369. https:\/\/doi.org\/10.1016\/j.canlet.2022.01.015.","journal-title":"Cancer Lett"},{"key":"3976_CR42","doi-asserted-by":"publisher","unstructured":"Adekoya TO, Richardson RM. Cytokines and chemokines as mediators of prostate cancer metastasis. Int J Mol Sci. 2020;21. https:\/\/doi.org\/10.3390\/ijms21124449.","DOI":"10.3390\/ijms21124449"},{"key":"3976_CR43","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3324\/haematol.2019.234476","volume":"106","author":"J Teramachi","year":"2021","unstructured":"Teramachi J, Tenshin H, Hiasa M, Oda A, Bat-Erdene A, Harada T, et al. TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma. Haematologica. 2021;106:1401\u201313. https:\/\/doi.org\/10.3324\/haematol.2019.234476.","journal-title":"Haematologica"},{"key":"3976_CR44","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1172\/JCI133334","volume":"130","author":"K Wang","year":"2020","unstructured":"Wang K, Gu Y, Liao Y, Bang S, Donnelly CR, Chen O, et al. PD-1 blockade inhibits osteoclast formation and murine bone cancer pain. J Clin Invest. 2020;130:3603\u201320. https:\/\/doi.org\/10.1172\/JCI133334.","journal-title":"J Clin Invest"},{"key":"3976_CR45","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/ncb3408","volume":"18","author":"RW Johnson","year":"2016","unstructured":"Johnson RW, Finger EC, Olcina MM, Vilalta M, Aguilera T, Miao Y, et al. Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow. Nat Cell Biol. 2016;18:1078\u201389. https:\/\/doi.org\/10.1038\/ncb3408.","journal-title":"Nat Cell Biol"},{"key":"3976_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9983","volume":"6","author":"MA Lawson","year":"2015","unstructured":"Lawson MA, McDonald MM, Kovacic N, Hua Khoo W, Terry RL, Down J, et al. Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche. Nat Commun. 2015;6:8983. https:\/\/doi.org\/10.1038\/ncomms9983.","journal-title":"Nat Commun"},{"key":"3976_CR47","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41586-019-1105-7","volume":"568","author":"CE Jacome-Galarza","year":"2019","unstructured":"Jacome-Galarza CE, Percin GI, Muller JT, Mass E, Lazarov T, Eitler J, et al. Developmental origin, functional maintenance and genetic rescue of osteoclasts. Nature. 2019;568:541\u20135. https:\/\/doi.org\/10.1038\/s41586-019-1105-7.","journal-title":"Nature"},{"key":"3976_CR48","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41392-023-01467-8","volume":"8","author":"H Xu","year":"2023","unstructured":"Xu H, Wang W, Liu X, Huang W, Zhu C, Xu Y, et al. Targeting strategies for bone diseases: signaling pathways and clinical studies. Signal Transduct Target Ther. 2023;8:202. https:\/\/doi.org\/10.1038\/s41392-023-01467-8.","journal-title":"Signal Transduct Target Ther"},{"key":"3976_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","volume":"8","author":"X Pang","year":"2023","unstructured":"Pang X, He X, Qiu Z, Zhang H, Xie R, Liu Z, et al. Targeting integrin pathways: mechanisms and advances in therapy. Signal Transduct Target Ther. 2023;8:1. https:\/\/doi.org\/10.1038\/s41392-022-01259-6.","journal-title":"Signal Transduct Target Ther"},{"key":"3976_CR50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00018-024-05526-3","volume":"82","author":"W Yao","year":"2024","unstructured":"Yao W, Zhao K, Li X. Platelet stimulation-regulated expression of ILK and ITGB3 contributes to intrahepatic cholangiocarcinoma progression through FAK\/PI3K\/AKT pathway activation. Cell Mol Life Sci. 2024;82:19. https:\/\/doi.org\/10.1007\/s00018-024-05526-3.","journal-title":"Cell Mol Life Sci"},{"key":"3976_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0939-5","volume":"9","author":"YY Gao","year":"2018","unstructured":"Gao YY, Zhang ZH, Zhuang Z, Lu Y, Wu LY, Ye ZN, et al. Recombinant milk fat globule-EGF factor-8 reduces apoptosis via integrin beta3\/FAK\/PI3K\/AKT signaling pathway in rats after traumatic brain injury. Cell Death Dis. 2018;9:845. https:\/\/doi.org\/10.1038\/s41419-018-0939-5.","journal-title":"Cell Death Dis"},{"key":"3976_CR52","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1016\/j.celrep.2017.02.012","volume":"18","author":"V Rapisarda","year":"2017","unstructured":"Rapisarda V, Borghesan M, Miguela V, Encheva V, Snijders AP, Lujambio A, et al. Integrin Beta 3 Regulates Cellular Senescence by Activating the TGF-beta Pathway. Cell Rep. 2017;18:2480\u201393. https:\/\/doi.org\/10.1016\/j.celrep.2017.02.012.","journal-title":"Cell Rep"},{"key":"3976_CR53","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1002\/mc.23803","volume":"63","author":"R Qiu","year":"2024","unstructured":"Qiu R, Deng Y, Lu Y, Liu X, Huang Q, Du Y. ITGB3-enriched extracellular vesicles mediate the formation of osteoclastic pre-metastatic niche to promote lung adenocarcinoma bone metastasis. Mol Carcinog. 2024;63:2190\u2013204. https:\/\/doi.org\/10.1002\/mc.23803.","journal-title":"Mol Carcinog"},{"key":"3976_CR54","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.phrs.2012.04.005","volume":"66","author":"R Roskoski Jr","year":"2012","unstructured":"Roskoski R Jr. ERK1\/2 MAP kinases: structure, function, and regulation. Pharm Res. 2012;66:105\u201343. https:\/\/doi.org\/10.1016\/j.phrs.2012.04.005.","journal-title":"Pharm Res"},{"key":"3976_CR55","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41392-023-01710-2","volume":"8","author":"L Chen","year":"2023","unstructured":"Chen L, Zhu S, Liu T, Zhao X, Xiang T, Hu X, et al. Aberrant epithelial cell interaction promotes esophageal squamous-cell carcinoma development and progression. Signal Transduct Target Ther. 2023;8:453. https:\/\/doi.org\/10.1038\/s41392-023-01710-2.","journal-title":"Signal Transduct Target Ther"},{"key":"3976_CR56","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0304-419x(96)00003-0","volume":"1287","author":"MT Brown","year":"1996","unstructured":"Brown MT, Cooper JA. Regulation, substrates and functions of src. Biochim Biophys Acta. 1996;1287:121\u201349. https:\/\/doi.org\/10.1016\/0304-419x(96)00003-0.","journal-title":"Biochim Biophys Acta"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03976-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03976-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03976-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:02:28Z","timestamp":1792533748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03976-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":56,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2026,11,11]]}},"alternative-id":["3976"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03976-6","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"7 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The TMA used in this experiment was approved by the Ethics Committee of Shanghai Outdo Biotech Company under the ethical approval number: SHYJS-CP-2207001. The experiments involving bone metastatic prostate cancer patients\u2019 tissues were conducted according to the ethical policies and procedures approved by the Medical Ethics Committee of First Affiliated Hospital of Guangzhou Medical University (ES-2025-096-05). Written informed consent was obtained from all participants, in accordance with institutional policies and the Declaration of Helsinki. All animal experiments were approved by the Animal Ethics Committee of Nanfang Hospital of Southern Medical University (NFYY-2020-0132).","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}